U.S. Capital Wealth Advisors LLC Has $969,000 Stock Position in Nutrien Ltd. (NYSE:NTR)

U.S. Capital Wealth Advisors LLC trimmed its stake in Nutrien Ltd. (NYSE:NTR - Free Report) by 19.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,513 shares of the company's stock after selling 4,699 shares during the quarter. U.S. Capital Wealth Advisors LLC's holdings in Nutrien were worth $969,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also made changes to their positions in the company. TD Private Client Wealth LLC grew its holdings in shares of Nutrien by 16.0% during the 1st quarter. TD Private Client Wealth LLC now owns 50,614 shares of the company's stock valued at $2,512,000 after acquiring an additional 6,988 shares in the last quarter. Envestnet Asset Management Inc. grew its stake in Nutrien by 27.8% in the first quarter. Envestnet Asset Management Inc. now owns 222,727 shares of the company's stock valued at $11,060,000 after purchasing an additional 48,464 shares in the last quarter. Minneapolis Portfolio Management Group LLC increased its position in Nutrien by 0.3% in the 1st quarter. Minneapolis Portfolio Management Group LLC now owns 368,065 shares of the company's stock worth $18,282,000 after purchasing an additional 1,117 shares during the last quarter. HM Payson & Co. purchased a new stake in shares of Nutrien during the 1st quarter worth about $65,000. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Nutrien by 9.4% during the 1st quarter. Bank of New York Mellon Corp now owns 499,678 shares of the company's stock valued at $24,819,000 after buying an additional 42,810 shares during the last quarter. 63.10% of the stock is owned by hedge funds and other institutional investors.

Nutrien Stock Performance

Shares of NYSE NTR traded down $1.30 during trading hours on Thursday, reaching $60.81. The stock had a trading volume of 1,847,841 shares, compared to its average volume of 2,191,114. The company has a market cap of $29.62 billion, a price-to-earnings ratio of 56.83, a PEG ratio of 1.17 and a beta of 0.80. Nutrien Ltd. has a twelve month low of $43.70 and a twelve month high of $65.08. The business's fifty day moving average is $59.24 and its two-hundred day moving average is $53.61. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.22 and a quick ratio of 0.59.

Nutrien (NYSE:NTR - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.24). The firm had revenue of $4.67 billion during the quarter, compared to the consensus estimate of $5.16 billion. Nutrien had a return on equity of 6.08% and a net margin of 2.05%. The firm's revenue for the quarter was down 5.4% compared to the same quarter last year. During the same period last year, the business earned $0.46 earnings per share. As a group, research analysts expect that Nutrien Ltd. will post 3.72 EPS for the current year.

Nutrien Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 18th. Stockholders of record on Monday, June 30th will be issued a $0.545 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 3.58%. Nutrien's payout ratio is presently 203.74%.

Wall Street Analysts Forecast Growth

NTR has been the topic of several analyst reports. Morgan Stanley increased their price target on shares of Nutrien from $60.00 to $65.00 and gave the stock an "equal weight" rating in a research note on Thursday, June 26th. Berenberg Bank increased their price target on Nutrien from $54.00 to $59.00 and gave the company a "buy" rating in a report on Tuesday, April 15th. The Goldman Sachs Group boosted their price objective on shares of Nutrien from $53.00 to $59.00 and gave the stock a "sell" rating in a research note on Friday, May 9th. Barclays raised their target price on shares of Nutrien from $61.00 to $64.00 and gave the company an "equal weight" rating in a research note on Monday. Finally, UBS Group boosted their target price on shares of Nutrien from $52.00 to $56.00 and gave the stock a "neutral" rating in a research report on Thursday, May 8th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $62.29.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.